The University of Southampton
University of Southampton Institutional Repository

Injection of botulinum toxin for treatment of chronic lateral epicondylitis: systematic review and meta-analysis

Injection of botulinum toxin for treatment of chronic lateral epicondylitis: systematic review and meta-analysis
Injection of botulinum toxin for treatment of chronic lateral epicondylitis: systematic review and meta-analysis
Objectives: lateral epicondylitis can be chronic and difficult to manage with conservative measures such as physical therapy and corticosteroid injection. We attempted to determine the efficacy of botulinumtoxin for the treatment of chroniclateral epicondylitis.

Methods: we searched PubMed, MEDLINE, CINAHL, Google Scholar, EMBASE, PEDro, and ISI web of Science databases from inception until November 2009. Studies were included if they used any formulation of botulinumtoxin A for treatment of chroniclateral epicondylitis and reported at least 1 pain outcome. One author extracted the relevant data using a standardized data extraction sheet and a second author checked the data. We performed a meta-analysis by computing effect sizes for each study separately for pain and grip strength at 3 months after injection. Impact of bias was assessed independently by 2 authors.

Results: the search found 10 studies relevant to the question. Four of these were randomized controlled trials that could be pooled in a meta-analysis. Results showed a moderate effect for pain favoring botulinumtoxin (effect size ?0.5, 95% CI ?0.9, ?0.1, I2 = 56%) at 3 months and a no effect for grip strength. Qualitative analysis of the studies that could not be pooled also showed improvement in pain, but was limited by potential bias.

Conclusions: present literature provides support for use of botulinumtoxin A injections into the forearm extensor muscles (60 units) for treatment of chronictreatment-resistant lateral epicondylitis. It is minimally invasive and can be performed in an outpatient setting
0049-0172
532-538
Galvin, Rose
f401c5d2-6765-4c90-bc0b-5727f9824dbd
Callaghan, Claire
c9efe904-14a6-4fa3-b1c6-7434f4470b8f
Chan, Wai-Sun
e91cea12-4711-4f66-b78e-1f3f3c6b0dd8
Dimitrov, Borislav D
366d715f-ffd9-45a1-8415-65de5488472f
Fahey, Tom
c0fd145a-af82-4c37-bce0-1c2e3e30c0f9
Galvin, Rose
f401c5d2-6765-4c90-bc0b-5727f9824dbd
Callaghan, Claire
c9efe904-14a6-4fa3-b1c6-7434f4470b8f
Chan, Wai-Sun
e91cea12-4711-4f66-b78e-1f3f3c6b0dd8
Dimitrov, Borislav D
366d715f-ffd9-45a1-8415-65de5488472f
Fahey, Tom
c0fd145a-af82-4c37-bce0-1c2e3e30c0f9

Galvin, Rose, Callaghan, Claire, Chan, Wai-Sun, Dimitrov, Borislav D and Fahey, Tom (2011) Injection of botulinum toxin for treatment of chronic lateral epicondylitis: systematic review and meta-analysis. Seminars in Arthritis and Rheumatism, 40 (6), 532-538. (doi:10.1016/j.semarthrit.2010.07.002,).

Record type: Article

Abstract

Objectives: lateral epicondylitis can be chronic and difficult to manage with conservative measures such as physical therapy and corticosteroid injection. We attempted to determine the efficacy of botulinumtoxin for the treatment of chroniclateral epicondylitis.

Methods: we searched PubMed, MEDLINE, CINAHL, Google Scholar, EMBASE, PEDro, and ISI web of Science databases from inception until November 2009. Studies were included if they used any formulation of botulinumtoxin A for treatment of chroniclateral epicondylitis and reported at least 1 pain outcome. One author extracted the relevant data using a standardized data extraction sheet and a second author checked the data. We performed a meta-analysis by computing effect sizes for each study separately for pain and grip strength at 3 months after injection. Impact of bias was assessed independently by 2 authors.

Results: the search found 10 studies relevant to the question. Four of these were randomized controlled trials that could be pooled in a meta-analysis. Results showed a moderate effect for pain favoring botulinumtoxin (effect size ?0.5, 95% CI ?0.9, ?0.1, I2 = 56%) at 3 months and a no effect for grip strength. Qualitative analysis of the studies that could not be pooled also showed improvement in pain, but was limited by potential bias.

Conclusions: present literature provides support for use of botulinumtoxin A injections into the forearm extensor muscles (60 units) for treatment of chronictreatment-resistant lateral epicondylitis. It is minimally invasive and can be performed in an outpatient setting

This record has no associated files available for download.

More information

e-pub ahead of print date: March 2011
Published date: June 2011
Organisations: Primary Care & Population Sciences

Identifiers

Local EPrints ID: 337413
URI: http://eprints.soton.ac.uk/id/eprint/337413
ISSN: 0049-0172
PURE UUID: 287ea84f-eb56-4ee9-988b-2c79f77cc3e4

Catalogue record

Date deposited: 25 Apr 2012 13:36
Last modified: 14 Mar 2024 10:53

Export record

Altmetrics

Contributors

Author: Rose Galvin
Author: Claire Callaghan
Author: Wai-Sun Chan
Author: Borislav D Dimitrov
Author: Tom Fahey

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×